Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels
- PMID: 28512557
- PMCID: PMC5419181
- DOI: 10.4084/MJHID.2017.028
Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels
Abstract
Objectives: To explore the incidence of vaso-occlusive crisis (VOC) in Blood Group "O" sickle cell disease (SCD) patients, and correlate it with the blood group and thrombospondin (TSP) levels.
Methods: In 89 consecutive SCD patients, blood samples were obtained for von Williebrand factor (vWF:Ag) antigen, collagen binding activity (CBA), ristocetin binding activity (RCo), blood group typing, C-reactive protein (CRP), high performance liquid chromatography (HPLC), Serum TSP 1 and TSP 2 levels, complete blood counts (CBC), lactic dehydrogenase (LDH) levels, liver function (LFT) and renal function tests (RFT) during VOC episodes and in steady state conditions.
Results: In steady state SCD patients (n=72), "O" blood group patients (n=37) showed a significantly higher median serum TSP 1 and TSP 2 levels as compared to non-O blood group patients [n=35] [p <0.05, Mann-Whitney test]; with an inverse relation between vWF:Ag, Factor VIII:C and TSP levels. Furthermore, the serum TSP 1 and TSP 2 levels were significantly higher in patients presenting with acute VOC [n=17], as well as in those with repeated VOC's (group 1, n=16), especially amongst blood group "O" patients [p, <0.05, Mann-Whitney test].
Conclusions: The study demonstrates an inverse relation between TSP and vWF levels, in blood group "O" SCD patients, with an upregulation of the TSP levels. Expectedly, during active VOC crisis, the TSP 1 and TSP 2 levels were significantly elevated.
Keywords: Blood groups; SCD; TSP 1; TSP 2; VOC; vWD.
Conflict of interest statement
Competing interests: The authors have declared that no competing interests exist.
Similar articles
-
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.Res Pract Thromb Haemost. 2020 Dec 18;5(1):197-203. doi: 10.1002/rth2.12460. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537544 Free PMC article.
-
Thrombospondin-1 and Vitamin D in Children With Sickle Cell Anemia.J Pediatr Hematol Oncol. 2019 Nov;41(8):e525-e529. doi: 10.1097/MPH.0000000000001368. J Pediatr Hematol Oncol. 2019. PMID: 30520760 Clinical Trial.
-
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20. Am J Kidney Dis. 2017. PMID: 27663041
-
Laboratory diagnosis and molecular classification of von Willebrand disease.Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506352 Review.
-
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230. Semin Thromb Hemost. 2005. PMID: 16276467 Review.
Cited by
-
Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®).Front Med (Lausanne). 2021 Oct 25;8:731102. doi: 10.3389/fmed.2021.731102. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34760898 Free PMC article.
-
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians.Blood Adv. 2022 Aug 9;6(15):4593-4604. doi: 10.1182/bloodadvances.2022007505. Blood Adv. 2022. PMID: 35420653 Free PMC article.
-
Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review.Exp Hematol Oncol. 2019 Sep 11;8:21. doi: 10.1186/s40164-019-0145-x. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 31528501 Free PMC article. Review.
References
-
- Luzzatto L. Sickle cell anemia in tropical Africa. Clin Hematol. 1981;3:757–784. - PubMed
-
- Serjeant GR. Sickle cell disease. Oxford, England: Oxford University Press; 1992.
-
- Bassiouny MR, Lamki Z, Elbanna N, Shah WM, White JM. Bahrain Med Bull. 1995;17:101–104.
-
- Daar S, Hussain HM, Gravell D, Nagel RL, Krishnamoorthy R. Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene. Am J Hematol. 2000;64:39–46. https://doi.org/10.1002/(sici)1096-8652(200005)64:1<39::aid-ajh7>3.3.co;2-r. - DOI - PubMed
-
- Makis AC, Hatzimichael EC, Bourantes KL. The role of cytokines in sickle cell disease. Ann Hematol. 2000;79:407–413. https://doi.org/10.1007/s002770000173. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous